ArticleFrontiers in pharmacology2025
Drug-related problems in elderly patients with AECOPD and pharmaceutical intervention practice: a prospective study.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pharmacist-led remote follow-up service for non-metastatic breast cancer patients: a prospective randomised controlled trial of pharmaceutical intervention.Frontiers in pharmacology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Elderly patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) face an elevated risk of drug-related problems (DRPs) owing to age-related decline in physiological reserve and multiple comorbidities. This study aims to systematically identify and categorize the DRPs of elderly patients with AECOPD, analyze their causes and risk factors, and evaluate the impact of pharmaceutical interventions on resolving DRPs. Methods: Elderly patients hospitalized with AECOPD at Gaochun Hospital Affiliated to Jiangsu University were enrolled in this prospective study from 1 January 2023 to 31 December 2024. Clinical pharmacists classified and documented DRPs using the Pharmaceutical Care Network Europe (PCNE) V9.1 Classification System, followed by targeted pharmaceutical interventions based on causes of DRPs. Results: A total of 544 AECOPD patients were included in the study. Among them, 393 DRPs were identified in 300 patients, resulting in an occurrence rate of 55.15%. "P2 Treatment safety" was the major DRPs ( Conclusion: The incidence of DRPs is high in elderly hospitalized patients with AECOPD in China. The number of comorbidities and prescription drugs are important predictors for DRPs. The active involvement of clinical pharmacists in the management of AECOPD patients can enhance both the safe and effective use of medications among elderly patients, as well as the overall quality of pharmaceutical care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.